BDRX
Biodexa Pharmaceuticals Plc
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 9/30/2026 | View on SEC |
| F-1 | 9/24/2026 | View on SEC |
| 424B3 | 9/15/2026 | View on SEC |
| 424B3 | 9/15/2026 | View on SEC |
| 424B3 | 9/15/2026 | View on SEC |
| 424B3 | 9/15/2026 | View on SEC |
| 424B3 | 9/15/2026 | View on SEC |
| 424B3 | 9/15/2026 | View on SEC |
| 424B3 | 9/15/2026 | View on SEC |
| 6-K | 9/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BDRX |
| Company Name | Biodexa Pharmaceuticals Plc |
| CIK | 1643918 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | X0 |
| Phone | 44 (0)1235 888300 |